HBV-IN-16
HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA) . cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1) [1].
Product Specifications
CAS Number
[2355225-38-4]
UNSPSC
12352005
Target
DNA/RNA Synthesis; HBV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-16.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=CC2=C1N=C(C3=CC=C(C=C3)OCCO[C@H]4C[C@H](C4)C(O)=O)C=C2
Molecular Formula
C22H20ClNO4
Molecular Weight
397.85
References & Citations
[1] Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human SOX30 shRNA (UAS) - Lentiviral human SOX30 shRNA (UAS) (25)